OLIVIA ECKSTEIN: Open Payments
NPI 1902357759 · BATESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 90 payments from 14 companies in 2025. Trend: 2023 $1,261 · 2024 $2,028 · 2025 $1,345
Food & beverage: $1,190Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $284 |
| ABBVIE INC. | 21 | $261 |
| Regeneron Healthcare Solutions, Inc. | 16 | $186 |
| Novartis Pharmaceuticals Corporation | 10 | $140 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
| UCB, Inc. | 4 | $88 |
| Amgen Inc. | 4 | $77 |
| Galderma Laboratories, L.P. | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| GENZYME CORPORATION | 2 | $36 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, Sotyktu, COSENTYX, Bimzelx, LIBTAYO.
Industry payments across IN — which companies pay providers there.
